These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23856248)

  • 1. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
    Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
    Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
    Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
    Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.
    Brauer PM; Zheng Y; Wang L; Tyner AL
    Cell Cycle; 2010 Oct; 9(20):4190-9. PubMed ID: 20953141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vemurafenib Inhibits Active PTK6 in
    Wozniak DJ; Hitchinson B; Gilic MB; Bie W; Gaponenko V; Tyner AL
    Mol Cancer Ther; 2019 May; 18(5):937-946. PubMed ID: 30926642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.
    Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL
    PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.
    Zheng Y; Tyner AL
    Eur J Clin Invest; 2013 Apr; 43(4):397-404. PubMed ID: 23398121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
    Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
    Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
    Zheng Y; Asara JM; Tyner AL
    J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.
    Hu Y; Sun H; Owens RT; Gu Z; Wu J; Chen YQ; O'Flaherty JT; Edwards IJ
    Neoplasia; 2010 Oct; 12(10):826-36. PubMed ID: 20927321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.
    Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
    Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
    Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
    Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
    Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
    Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression.
    Lang YD; Chen HY; Ho CM; Shih JH; Hsu EC; Shen R; Lee YC; Chen JW; Wu CY; Yeh HW; Chen RH; Jou YS
    Nat Commun; 2019 Dec; 10(1):5716. PubMed ID: 31844057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.
    Chen ZH; Yu YP; Tao J; Liu S; Tseng G; Nalesnik M; Hamilton R; Bhargava R; Nelson JB; Pennathur A; Monga SP; Luketich JD; Michalopoulos GK; Luo JH
    Gastroenterology; 2017 Oct; 153(4):1120-1132.e15. PubMed ID: 28245430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
    Baruah MM; Khandwekar AP; Sharma N
    Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
    Putzke AP; Ventura AP; Bailey AM; Akture C; Opoku-Ansah J; Celiktaş M; Hwang MS; Darling DS; Coleman IM; Nelson PS; Nguyen HM; Corey E; Tewari M; Morrissey C; Vessella RL; Knudsen BS
    Am J Pathol; 2011 Jul; 179(1):400-10. PubMed ID: 21703419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
    Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
    Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.